Medication info

Glophen Injection (Ibuprofen)

Prescription medicationInjections
Ingredient · strength
Ibuprofen›400mg / 1 vial
Manufacturer / importer
Keeps Biopharma Co., Ltd.
Appearance
A colorless or light yellow liquid filled in a transparent plastic container for injection.
Packaging
100 milliliters/vial
Approval status
Active

MFDS item code 202202367 · Notified 2022.06.07

Summary

Main use
Relief of moderate to severe pain (as an adjunct to opioid analgesics); reduction of fever
Who uses it
Adults · Children
Adult dosage
Administer this medication at the minimum effective dose that meets each patient's treatment goals for the shortest possible duration. After the initial dose, adjust the dose and frequency of administration as appropriate based on the patient's condition. This medication is a premixed formulation and must be administered undiluted. Use only when one package (ibuprofen 400mg) can replace the required dose; do not use partial contents of a package. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy with opioid analgesics (morphine) for the management of moderate to severe pain ⦁ Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. (2) Fever reduction ⦁ Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. Before administration, inspect the injection visually for particulate matter or discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.
Children's dosage
6 months to under 12 years: Administer 10mg/kg per dose (up to a maximum of 400mg) intravenously as needed every 4~6 hours; each administration must take at least 10 minutes. The maximum daily dose is 40mg/kg or 2,400mg, whichever is lower. 12 years to under 17 years: Administer 400mg intravenously as needed every 4~6 hours; each administration must take at least 10 minutes. The maximum daily dose is 2,400mg.

Ingredients

Manufacturer
Keeps Biopharma Co., Ltd.

Efficacy & effects

Relief of moderate to severe pain (as an adjunct to opioid analgesics); reduction of fever

  • Moderate to severe pain
  • fever
View approved original text

This medication is used as an adjunct therapy along with narcotic analgesics to control pain ranging from moderate to severe. It also has antipyretic effects, helping to alleviate pain and fever simultaneously. Therefore, it is effectively used for pain control and fever reduction.

Dosage and Administration

Adult dosage

Administer this medication at the minimum effective dose that meets each patient's treatment goals for the shortest possible duration. After the initial dose, adjust the dose and frequency of administration as appropriate based on the patient's condition. This medication is a premixed formulation and must be administered undiluted. Use only when one package (ibuprofen 400mg) can replace the required dose; do not use partial contents of a package. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy with opioid analgesics (morphine) for the management of moderate to severe pain ⦁ Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. (2) Fever reduction ⦁ Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The infusion time must be at least 30 minutes. Before administration, inspect the injection visually for particulate matter or discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.

Children's dosage

6 months to under 12 years: Administer 10mg/kg per dose (up to a maximum of 400mg) intravenously as needed every 4~6 hours; each administration must take at least 10 minutes. The maximum daily dose is 40mg/kg or 2,400mg, whichever is lower. 12 years to under 17 years: Administer 400mg intravenously as needed every 4~6 hours; each administration must take at least 10 minutes. The maximum daily dose is 2,400mg.

Precautions

This medication may increase the risk of serious cardiovascular problems such as myocardial infarction and stroke in patients with cardiovascular diseases or risk factors. The risk is particularly heightened during long-term use or high doses, so it is essential to carefully monitor for abnormal symptoms during administration. Furthermore, this medication can cause serious gastrointestinal issues, such as gastrointestinal bleeding, ulcers, and perforations. Elderly patients or long-term users are at a higher risk of gastrointestinal adverse reactions and should exercise caution. Patients with a history of gastrointestinal ulcers or bleeding, severe liver, kidney, or heart dysfunction, and those allergic to the components of this medication should not use it. Asthma patients or those who have previously experienced allergic reactions to aspirin and other non-steroidal anti-inflammatory drugs should also refrain from taking this medication. Pregnant women in the late stages of pregnancy should avoid this medication due to the risk of premature closure of the ductus arteriosus in the fetus. During the use of this medication, do not exceed the recommended dosage and avoid concurrent use with other non-steroidal anti-inflammatory drugs. Patients with hypertension may experience increased blood pressure with this medication, so regular monitoring of blood pressure is necessary, and caution is advised for patients with heart failure or edema. Patients with impaired kidney function or dehydration may develop kidney damage while taking this medication, so close observation is required. In cases of liver dysfunction, careful monitoring for any changes in liver function during the use of this medication is necessary, and if abnormal symptoms arise, discontinue its use immediately. Hematological adverse reactions such as anemia or platelet dysfunction may occur; therefore, regular blood tests should be conducted during long-term use. This medication can cause serious allergic reactions, such as anaphylaxis. If hypersensitivity symptoms occur, seek emergency treatment immediately. If severe rashes, blisters, or redness appear on the skin, discontinue the medication immediately and consult medical personnel. This medication may mask the symptoms of infections, so careful diagnosis is warranted in cases of suspected infection. It should not be used in patients with aspirin hypersensitive asthma and should be administered with caution to asthma patients. If symptoms such as blurred vision or decreased vision occur, discontinue use and undergo an ophthalmological examination. If symptoms of aseptic meningitis appear, the relationship with this medication should be confirmed. This medication can interact with other drugs; therefore, caution is necessary when using it together with aspirin, anticoagulants, ACE inhibitors, diuretics, lithium, methotrexate, and selective serotonin reuptake inhibitors. During pregnancy, particularly after 20 weeks of gestation, it should be used at the lowest effective dosage for the shortest duration possible to minimize the risk of fetal renal dysfunction and oligohydramnios and should be avoided in the late stages of pregnancy. During breastfeeding, this medication may be transferred to breast milk, potentially causing adverse reactions in infants; thus, it is advisable to discontinue either breastfeeding or medication administration. Safety in children under 6 months has not been established, so it is best not to use this medication. Elderly individuals are at a higher risk of adverse effects due to decreased bodily functions; therefore, dosage adjustment and close monitoring are essential. In cases of overdose, serious symptoms such as dizziness, nausea, vomiting, liver dysfunction, kidney failure, respiratory distress, and hypotension may occur. If overdose is suspected, discontinue use immediately and seek prompt medical attention.

Side effects

Shock, anaphylactic reaction, mimic symptoms, chills, difficulty breathing, hypotension, decreased hematocrit, decreased hemoglobin, anemia, aplastic anemia, hemolytic anemia, agranulocytosis, neutropenia, leukopenia, thrombocytopenia, impaired platelet function, eosinophilia, peptic ulcer, gastrointestinal ulcer, gastrointestinal bleeding, perforation, ulcerative colitis, bloody stool, gastritis, pancreatitis, hematemesis, Crohn's disease, loss of appetite, nausea, vomiting, abdominal pain, dyspepsia, diarrhea, upper abdominal discomfort, epigastric pain, thirst, stomatitis, abdominal bloating, oral ulcer, constipation, black stool, Stevens-Johnson syndrome, toxic epidermal necrolysis, Liel syndrome, phototoxic reaction, drug rash with eosinophilia and systemic symptoms, DRESS syndrome, angioedema, vesicular dermatitis, erythema multiforme, papular rash, skin redness, blisters, rash, exfoliative dermatitis, acute generalized exanthematous pustulosis (AGEP), hepatitis, jaundice, abnormal liver function, liver dysfunction, hypersensitivity, anaphylactic reaction, asthma attack, urticaria, eczema, purpura, rash, pruritus, asthma, bronchoconstriction, difficulty breathing, wheezing, scotoma, visual impairment, hearing loss, tinnitus, taste abnormalities, dizziness, drowsiness, vertigo, depression, headache, cerebrovascular accident, irritability, aseptic meningitis, meningitis, increased blood pressure, palpitations, heart failure, myocardial infarction, angina pectoris, acute kidney failure, oliguria, hematuria, protein in urine, increased serum creatinine, hyperkalemia, interstitial nephritis, nephritic syndrome, renal papillary necrosis, decreased urine output, generalized edema, dyspnea, lethargy, Conus syndrome, periorbital edema, facial edema, malaise, fever, nosebleed, edema, peripheral edema, nausea, abdominal distension, headache, hemolysis, drowsiness, peripheral edema, urination disorders, anemia, decreased hemoglobin, dyspepsia, wound hemolysis, abdominal discomfort, cough, hypokalemia, eosinophilia, hypoalbuminemia, neutropenia, increased hematuria, hypernatremia, hypertension, hypoalbuminemia, hypotension, diarrhea, bacterial pneumonia, increased serum LDH, thrombocytosis, bacteremia, injection site pain, nausea, dizziness, abdominal pain, loss of consciousness, convulsions, metabolic acidosis, renal failure, respiratory depression

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent contact with air, and it is best kept at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

A colorless or light yellow liquid filled in a transparent plastic container for injection.

Package unit

100 milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.